RecruitingNCT06824623

Readmission and Dehydration Prevention in Patients With Elective Ileostomy

Multicenter Prospective Observational Study to Prevent the Risk of REadmission and DEhydration of Patients With ileoSTOmy in Elective Colorectal Surgery

Sponsor

Multidisciplinary Italian Study group for STOmas (MISSTO)

Enrollment

300 participants

Start Date

Jun 1, 2025

Study Type

OBSERVATIONAL

Conditions

Colorectal Surgery Ileostomy - Stoma Dehydration

Summary

The goal of this prospective observational study is to evaluate the adherence to DRIP score calculation and the application rate of each proposed item to prevent dehydration and readmission in patients undergoing ileostomy creation after elective colorectal resection different Italian colorectal surgical centers. The primary endpoint is to verifythe application rate of DRIP score calculation and protocol items. Secondary endpoints are 30, 90, and 180-day total and dehydration readmission rates.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a program to prevent dehydration and reduce hospital readmissions in patients who have had elective surgery. The program may include electrolyte replacement, hydration monitoring, and education before and after discharge. **You may be eligible if...** - You are 18 or older - You are scheduled for or have recently had elective (non-emergency) surgery - You are at risk for dehydration after surgery - You are being discharged home (not to another care facility) **You may NOT be eligible if...** - You are on fluid restriction due to heart or kidney conditions - You have severe swallowing difficulties - You are already severely dehydrated requiring hospital-level care - You are having emergency rather than planned surgery Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.